Latest news with #Devgan
Vogue
4 days ago
- Entertainment
- Vogue
What Exactly Is the Liquid Rhinoplasty? And Would It Work for Me?
Last fall, after decades of vision so poor I couldn't recognize my closest friends across a small room without glasses, I paid $10,000 for ICL surgery, a newish LASIK alternative in which permanent contact lenses are installed in one's eyeballs. Besides the somewhat daunting, monthlong course of prescription eye drops that followed, recovery was swift. I've had no major medical complications, only subtle psychological ones: Improving my vision, I realized, impaired the way I saw myself. For the first time in as long as I could remember, I looked in the mirror and saw only my face staring back at me. No brow-hiding frames, no eye-distorting lenses. And most crucially, perhaps, was my nose: bare, no longer horizontally bifurcated by a ridge of black acetate. In a good mood, on a good day, my nose is 'striking' or 'distinguished.' It has 'character,' to quote my mother. In a bad mood, on a bad day, it is simply crooked. 'I'm so glad she never fixed it,' a famous artist recently told a mutual friend, upon meeting me. Meant as a compliment, I, of course, interpreted it as insult. Should I have fixed it? A basketball to the face in middle school left a hairline fracture and with it a slight asymmetry I was always aware of without really caring about. But now the asymmetry shone (sometimes, especially in photographs, literally: reflecting a spot of glare back at the camera). My friends and family all called me crazy whenever I mentioned it, but their reassurances were of little value. It wasn't that I didn't believe them—I didn't care what they looked like either!—but I wanted a professional opinion. One drizzly spring morning, I entered the sprawling, multistory Park Avenue office of plastic surgeon Lara Devgan, MD, whose Instagram follower count approaches 1 million and whose proprietary skin-care fans include Kim Kardashian and Jennifer Aniston. Known for what she calls 'facial optimization,' Devgan tends toward an approach made up of 'tweaks,' as she refers to them—the facial equivalent of having an old dress tailored rather than getting a fabulous new one custom-made. 'So you have a 'deep radix,' ' she said, petting the depression at the top of my nose with her index finger. There was also, she went on, a 'widening of the dorsal nasal aesthetic lines': the bridge, in lay terms. There was 'some crookedness,' which she said was 'likely the site of prior trauma.' Lastly, I suffered from what she described as 'a little bit of a bulbous and slightly droopy nasal tip.' Finally, some honesty, I thought to myself. A good, old-fashioned rhinoplasty could, of course, make my nose smaller and less crooked. It would also cost close to $20,000, require general anesthesia, take up to a full year to see the final results, and turn me into a person who got a purely elective nose job at an age (37) that was, in my opinion, decades past the point of utility. But there were other methods. 'One of the hallmarks of modern plastic surgery is customizability,' Devgan said. Some well-placed injections of hyaluronic acid—which functions almost like a cartilage graft—at the top of the nose (to lessen the prominence of the bump) might 'optimize' my appearance, as she put it. 'We don't have to have you look textbook to be happy.' Devgan was describing, essentially, a nonsurgical nose job—or a 'liquid rhinoplasty'—a procedure that has been growing in popularity without being, in itself, new. (The practice of injecting the nose with various liquids dates back to the turn of the 20th century, when precarious substances including oils and waxes were used.) The first filler made of hyaluronic acid—which is also used topically for its moisturizing properties—was approved for cosmetic use by the FDA in 2003, and in the years since its effects can be seen everywhere from the enviably sculpted cheekbones of influencers to the trout-y mouths of the ladies populating Bravo and so many of the women who love to hate them.
Yahoo
28-05-2025
- Business
- Yahoo
$2M supercomputer powered by NVIDIA delivers 80X leap in chip and drug design
Cadence Design Systems has launched the Millennium M2000 Supercomputer, a powerful new platform built with NVIDIA's latest Blackwell architecture. Announced during CadenceLIVE Silicon Valley 2025, the system promises significant speed and energy efficiency gains for workloads across semiconductor design, life sciences, aerospace, and hyperscale computing. Designed for both cloud and on-premises deployment, the Millennium M2000 combines NVIDIA HGX B200 systems, RTX PRO 6000 Blackwell Server Edition GPUs, and Cadence's full stack of solvers. The system delivers up to 80X faster performance and 20X lower power usage compared to CPU-based predecessors. By co-optimizing software and hardware, the platform enables simulations that previously required hundreds of CPUs and days to now complete in under 24 hours. Anirudh Devgan, president and CEO of Cadence, described the system as a milestone for accelerated design. 'The Millennium M2000 Supercomputer will drive the next leap in AI-accelerated engineering by leveraging our massively scalable solvers, dedicated NVIDIA Blackwell-accelerated computing and AI to help designers continue to push the limits of what is possible,' he said. One key advantage of the M2000 is its ability to handle large-scale simulations in semiconductor and 3D-IC design. The system supports advanced analysis of power, thermal, stress, and electromagnetic properties in a single unified platform. According to Cadence, engineers can now complete chip-level power integrity simulations in a single day, compared to the two weeks needed with traditional CPU clusters. Cadence and NVIDIA engineering teams used the company's Palladium and Protium platforms during the development of Blackwell, helping validate chip designs with faster turnaround times. 'This is years in the making,' Devgan noted. 'It's a combination of advancement on the hardware and system side by NVIDIA — and then, of course, we have to rewrite our software to take advantage of that.' Beyond chips, the M2000 enables high-fidelity modeling of complex systems, including autonomous machines and digital twin environments. Designers can now run precision virtual wind tunnels and simulate system behavior at scale, using Cadence tools integrated with NVIDIA's Omniverse APIs. The result is faster development of AI-powered systems in sectors like aerospace and robotics. NVIDIA founder and CEO Jensen Huang highlighted the growing demand for such infrastructure. 'AI is going to infuse into every single aspect of everything we do. Every company will be run better because of AI, or they'll build better products because of AI,' he said. 'The work that we're doing together recognizes that there's a whole new type of factory that's necessary. We call them AI factories.' In life sciences, the M2000 supercomputer accelerates molecular design through Cadence's Orion platform, which now integrates NVIDIA BioNeMo NIM microservices and Llama Nemotron models. Pharmaceutical researchers can explore more design variations faster, helping reduce the time required to identify viable drug candidates. Cadence said simulations that previously took days using massive CPU clusters can now be completed overnight. Using the Fidelity CFD Platform and GB200 Grace Blackwell Superchips, the company demonstrated complex fluid dynamics simulations running in under 24 hours. The Millennium M2000 is expected to cost around $2 million in its standard configuration, which includes approximately 32 NVIDIA Blackwell GPUs. It is available both via the cloud and as a standalone appliance. Early adopters include MediaTek, Boom Supersonic, Ascendance, Treeline Biosciences, and Supermicro. NVIDIA also announced plans to acquire 10 Millennium systems to accelerate its own chip design workflows. 'This is a big deal for us,' Huang said. 'We started building our data center to get ready for it.'
Yahoo
14-05-2025
- Business
- Yahoo
Cadence Design Systems raises outlook after strong Q1
This story was originally published on Manufacturing Dive. To receive daily news and insights, subscribe to our free daily Manufacturing Dive newsletter. Cadence Design Systems has raised its earnings outlook for the year, betting on continued momentum following a better-than-expected first quarter amid trade uncertainty. The chip design software company revised its full-year revenue outlook to a range of $5.15 billion to $5.23 billion, an estimated increase of $10 million from a few months ago. Even as tariff talks escalated and pressured customers, executives said on an April 28 earnings call that demand for the company's products and services has been resilient. Cadence generated Q1 revenue of $1.24 billion, a 23% increase year over year. Despite broader economic uncertainty, companies are continuing to invest in research and development for their next-generation technology designs, fueled by artificial intelligence and data center build-outs. Supporting this effort is Cadence, one of the major U.S. providers of software, services and hardware for designing products like microchips, planes, automobiles and digital systems. The company's quarter-end backlog totaled $6.4 billion, according to its earnings report. Notably, the company saw a 40% YoY increase from its semiconductor IP segment, which benefited from AI and foundry ecosystem buildout, according to the report. Meanwhile, its core electronic design automation segment grew 16% YoY, driven by momentum for Cadence's chip design automation tool, the Cerebrus Intelligent Chip Explorer. The company posted net income of $273.6 million in Q1, up 10.4% YoY. While tariffs have rattled markets and spurred companies to reevaluate their operations, Cadence has been largely immune because software and services are not subject to tariffs, according to President and CEO Anirudh Devgan. The company's supply chain is diversified enough that Devgan said he doesn't believe tariffs will have an effect even as the hardware business is exposed. 'On the other hand, we continue to monitor the situation,' Devgan said on the call. 'It is a dynamic situation. But I feel that we are more resilient…and we feel that we have enough confidence and visibility to raise our outlook for 2025.' In addition to stronger full-year revenue, Cadence revised its outlook to include an operating margin as high as 31.25%. It also expects earnings to be as high as $4.31 per share. As AI evolves and reshapes chip and system development, Devgan said on the call that Cadence's portfolio is well positioned for future growth. 'I'm pleased with our Q1 results and the continued momentum of our business,' Devgan said. 'The growing complexity of chip and system design, coupled with the transformative potential of AI-driven automation, creates significant opportunities for our products to enable and empower our customers.' Cadence is collaborating with a host of partners on technology advancements, including with Nvidia on its Grace Blackwell chip. It also officially joined the Intel Foundry Accelerator Design Services Alliance, which Degan said will help foundry customers remain at the forefront of innovation. Recommended Reading Chip design software maker Cadence revenue skyrockets with AI demand Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Time of India
12-05-2025
- Health
- Time of India
Doctor practices while suspended, Punjab Medical Council complains to cops but revokes suspension
Representative image The Punjab Medical Council (PMC) restored the licence of a surgeon who continued to practice while under suspension. This, despite having urged the police to act against the doctor on the grounds that doing so was illegal. Yet, the National Medical Commission refuses to take up the patient's complaint against this decision of the PMC. The PMC declined to reveal if the suspended surgeon fulfilled the conditions its ethics committee had recommended for him to be allowed to resume practice - a root cause analysis of the death of two patients who he operated on, and a certificate showing that he had got himself trained in laparoscopic hysterectomy . Operation Sindoor 'Our job is to hit target, not to count body bags': Air Marshal Bharti on Op Sindoor Precautionary blackout imposed across parts of Rajasthan, Punjab 'Indian Navy was in position to strike Karachi': Vice Admiral on Operation Sindoor TOI asked PMC why its Dec 2024 order restoring the licence of Dr Praveen Devgan cited the high court order of Nov 20, 2024 when the court had not ordered restoration of licence. In response, it produced yet another council order dated April 25, 2025, which claimed that the decision to restore the licence was taken in the general body meeting on Sept 25, 2024 after receiving an application from Dr Devgan at the end of the six-month suspension period. PMC was mum on Dr Devgan continuing to practice during the period of suspension. "The case filed by Dr Devgan in July 2024 against his suspension was still pending on Sept 25. How did PMC take a decision to restore his licence before the court had decided the case?" asked the complainant, Gokul Aneja, who has alleged medical negligence in the death of his wife Sunita Aneja. She was diagnosed with multiple fibroids and underwent laparoscopic hysterectomy by Dr Parveen Devgan on Oct 1, 2018. Dr Devgan's petition in HC was "disposed of as withdrawn" on Nov 20 last year because he had moved an application seeking to withdraw the petition. The court had neither stayed his suspension nor examined its merits. In PMC's general body meeting held on July 21, 2023 "all the council members unanimously decided that Dr Parveen Devgan failed to demonstrate due skill and care towards patients". PMC's final order on Dec 21, 2023, suspended his registration for six months and debarred him from practice. The order cited the ethics committee' recommendations. These included that he be restrained from performing any laproscopic procedure in his own hospital or in any other hospital till he submitted a root cause analysis of the deaths, done by a higher institute like PGI Chandigarh doing and imparting training in laparoscopic hysterectomy, and that he get trained in laparoscopic hysterectomy from a recognised institute and submit the certificate to PMC. The committee stated that Dr Devgan should be initially restrained for a minimum of six months that could be extended further till he complied with the two conditions of root cause analysis and certificate of training. When Dr Devgan applied to Fortis Hospital, Noida for training in laparoscopic hysterectomy along with other procedures in laparoscopy, the hospital informed him that he could not be trained in laparoscopic gynae procedures "as by NMC guidelines you do not possess required qualification of post-graduation in Obs & Gynae". "It is unethical and unlawful for a general surgeon to do gynaecological training or procedures as he/she does not have the required qualification to do so," stated the hospital letter in May 2024. On receiving information that Dr Devgan was practicing despite suspension of licence, civil surgeon of Amritsar inspected the hospital on April 5, 2024, and found that he was performing operations. She informed the PMC and the police in Amritsar. The PMC urged the commissioner of police in Amritsar to take action as practising while his licence was suspended was illegal, and against the Punjab Medical Registration Act and the National Commission Act. Get the latest lifestyle updates on Times of India, along with Mother's Day wishes , messages , and quotes !
The Print
05-05-2025
- Health
- The Print
Prunes May Help Prevent Osteoporosis and Improve Bone Health
New Delhi [India], May 5: Osteoporosis is a condition that weakens bones, making them fragile and more prone to fractures. This condition is particularly common among older adults and post-menopausal women, often progressing without noticeable symptoms until a fracture occurs. While exercise and a balanced diet are crucial for maintaining bone health, certain foods provide specific nutrients that can significantly strengthen bones. Among these, Chilean prunes stand out for their potential in preventing and managing osteoporosis, offering a natural and effective way to support bone health. A study conducted by Florida State University, published in the British Journal of Nutrition, evaluated the impact of daily prune consumption among 89 postmenopausal women. The results were encouraging: women who included prunes in their diets for a year saw improvements in their bone density levels, a key marker in reducing the risk of osteoporosis and related fractures. Researchers believe the bone-protective benefits of prunes may be linked to their antioxidant content and anti-inflammatory properties, both of which contribute to stronger, healthier bones. Kavita Devgan, a leading Dietitian, holistic health consultant and an eminent writer said, 'To prevent osteoporosis, eating a diet rich in bone-healthy nutrients is important. An overhaul of diet to consciously include functional foods that are specifically good for the bones is important. Here prunes, which are dehydrated plums and loaded with bone-healthy nutrients, fit in fabulously.' 'Prunes are easy to add to everyday meals or snack routines and could be a simple yet powerful step toward protecting long-term bone health, especially for women entering menopause, a time when bone loss risk increases sharply', add Ms Devgan. Speaking on the India market Mr. Sumit Saran, India Representative of Chilean prunes remarked. 'Chile is known as one of the world's largest growers and suppliers of prunes. Chilean prunes are recognized globally for their high quality. Just visit your dry fruit retailer or head to the grocery store and ask for Chilean prunes.' (ADVERTORIAL DISCLAIMER: The above press release has been provided by HT Syndication. ANI will not be responsible in any way for the content of the same) This story is auto-generated from a syndicated feed. ThePrint holds no responsibility for its content.
